- Description
- Specifications
Catalog #: HIV-113
Description:
The E.Coli derived protein contains the full-length sequence of N-terminal epitopes of HIV-I gp41 288 amino acids (466-753) immunodominant regions gp41L. The protein is fused to b-galactosidase (114 kDa) at N-Terminus.
Source:
Escherichia Coli.
Purity:
Greater than 95.0% as determined by HPLC analysis & SDS-PAGE.
Formulation:
10mM Na2CO3, 10mM Na3EDTA, 10mM M?-mercaptoethanol, 0.05% tween-20.
Stability:
HIV-1 gp41 Long although stable at 4 °C for 1 week, should be stored below -18 °C.
Please prevent freeze thaw cycles.
Specificity:
Immunoreactive with all sera of HIV-1 infected individuals.
Physical Appearance:
Sterile filtered colorless clear solution.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
